NCT02970500 2023-03-23
CogMet
CHU de Quebec-Universite Laval
Phase 2 Terminated
Clinical Trials
11 trialsNCT00031798 2021-09-09
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Wake Forest University Health Sciences
Phase 3 Terminated
NCT00418691 2020-09-23
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01164956 2019-04-26
Methylphenidate for Cancer-Related Fatigue
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT00516269 2018-01-03
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01773837 2017-05-09
Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients
Clinica Universidad de Navarra, Universidad de Navarra
Phase 3 Terminated
NCT01100658 2015-03-27
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
University of Minnesota
Phase NA Terminated
NCT00593853 2014-06-04
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy
University Health Network, Toronto
Phase 2 Terminated
NCT01348607 2014-02-21
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
University of South Florida
Phase 2 Terminated
NCT00069927 2014-02-03
Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression
University of South Florida
Phase 2 Terminated
NCT00273741 2009-12-07
Ritaline
University Hospital, Grenoble
Phase 3 Terminated